← Eichor
Study identifier: NCT07250022 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Detection of Residual Caries on Class II Cavity Walls in Primary Teeth Following Atraumatic Restorative Treatment (ART)

Condition: Primary Dental Caries  ·  Sponsor: Çanakkale Onsekiz Mart University

PhaseNA
Planned participants212
Who can joinAll sexes, 4 Years to 9 Years
Healthy volunteersYes

About this study

The primary aim of this study is to compare the diagnostic agreement and effectiveness of three different methods-Fluorescence-Aided Caries Excavation (FACE), caries detection dye, and clinical observation-in detecting residual caries remaining on cavity walls of primary teeth following Atraumatic Restorative Treatment (ART). Through this comparison, the study seeks to identify the method that provides more reliable and accurate results, thereby contributing to clinical practice by guiding clinicians and supporting the development of strategies to enhance the long-term success of ART.

This description comes directly from the study's public registry record.

Talk to the study team

Burak Çarıkçıoğlu, Associate Professor  ·  00905054956091  ·  carikcioglub@gmail.com

İdil Ay Şimşek, Research Assistant  ·  00905549907321  ·  ay.idil@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Canakkale Onsekiz Mart UniversityÇanakkale, Kepez, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07250022